Market News How it works Learn FAQ
| RCT 0.132 73.46% | NU 12.36 -18.47% | EWZ 33.885 -20.44% | TGL 0.254 14.67% | SRTM 0.326 -24.24% | BBD 2.855 -29.85% | ITUB 7.6 -21.41% | AZTR 1.615 125.87% | SHFS 0.103 -22.21% | XP 15.575 -48.78% | GCDT 0.1361 -22.71% | CLRO 4.79 47.38% | SOXL 91.64 9.67% | SPCX 149.92 1.65% | NWGL 0.0829 1.10% | PBR 21.94 -16.13% | NVD 3.99 -4.77% | SGRY 23.0703 46.48% | TSLL 10.9599 12.29% | VALE 11.99 -3.31% | RBNE 0.1701 -10.47% | CRWV 57.4626 5.95% | INTC 90.785 4.40% | NVDA 216.2072 2.49% | SOXS 47.41 -9.63% | BITO 10.77 -0.55% | ABEV 2.8 -15.15% | IREN 26.5486 6.60% | JBLU 2.295 -12.57% | NOK 8.625 5.96% | XTND 2.2 24.29% | SPRC 1.5001 37.62% | GPUS 0.1782 5.51% | TQQQ 69.14 4.30% | SBS 4.765 -25.55% | INTR 4.6286 -35.62% | TSLG 5.48 12.53% | RWM 14.435 -0.79% | TSLA 395.443 6.24% | SPDN 8.475 -0.76% | SQQQ 37.975 -4.30% | AAL 12.2055 0.79% | SID 0.9269 -21.45% | GGB 4.765 -6.57% | PBR-A 19.3388 -17.81% | RENT 2.9015 26.15% | LUCD 0.5155 25.43% | CIFR 8.1475 2.61% | KORU 10.9537 3.53% | WULF 12.08 6.71%
SNSmith & Nephew plc logo

Smith & Nephew plc (SNN)

New York Stock Exchange · Currency in USD
$30.56 ▼ -0.28 (-0.89%)
As of Oct 26, 12:32 PM ET. Market open.

Summary

Previous Close
$30.83
Open
$30.54
Day's Range
$30.33 – $30.65
52 Week Range
$26.12 – $37.09
Volume
690,857
Avg. Volume
1,565,376
Market Cap
$12.81B
Beta (5Y Monthly)
0.69
PE Ratio (TTM)
20.00
EPS (TTM)
$1.51
Earnings Date
Feb 23, 2027
Forward Dividend & Yield
$0.62 (2.04%)
Ex-Dividend Date
Oct 2, 2026
1y Target Est
$31.91

Profile: Smith & Nephew plc

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
18,362
CEO
Deepak S. Nath

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Earnings

Next report: Tue, Feb 23, 2027
EPS estimate $1.21 · Revenue est. $3.32B
DateEst.Actual
Aug 4, 2026$0.94$0.95Beat
Mar 2, 2026$1.16$1.18Beat
Aug 5, 2025$0.79$0.86Beat
Feb 25, 2025$0.92$0.94Beat
Oct 31, 2024$0.80$0.50Miss
Aug 1, 2024$0.79$0.75Miss

Analyst view

Consensus price target
$31.91 ▲ +4.4%
Range $30.00 – $33.88
Rating: Hold
Buy 26% · Hold 65% · Sell 9%

Get free alerts on SNN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.